Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$8.22 USD
+0.05 (0.61%)
Updated May 10, 2024 04:00 PM ET
After-Market: $8.22 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Pediatrix Medical Group (MD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.07 | $10.00 | $8.00 | 11.02% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Pediatrix Medical Group comes to $9.07. The forecasts range from a low of $8.00 to a high of $10.00. The average price target represents an increase of 11.02% from the last closing price of $8.17.
Analyst Price Targets (7 )
Broker Rating
Pediatrix Medical Group currently has an average brokerage recommendation (ABR) of 3.13 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 3.13 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, one is Strong Buy, representing 12.5% of all recommendations. A month ago, Strong Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/5/2024 | SVB Securities | Whit Mayo | Hold | Hold |
2/21/2024 | Truist Securities | David S Macdonald | Hold | Hold |
2/21/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Hold | Hold |
11/2/2023 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.13 |
ABR (Last week) | 3.13 |
# of Recs in ABR | 8 |
Average Target Price | $9.07 |
LT Growth Rate | 4.70% |
Industry | Medical Services |
Industry Rank by ABR | 87 of 252 |
Current Quarter EPS Est: | 0.33 |